B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 270 KRW 2.47% Market Closed
Market Cap: 113.2B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

11.5
Current
14.7
Median
4.2
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
11.5
=
Enterprise Value
71.7B KRW
/
EBITDA
6.2B KRW
All Countries
Close
Market Cap EV/EBITDA
KR
Bio-FD&C Co Ltd
KOSDAQ:251120
113.2B KRW 11.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -219 796.6
US
Abbvie Inc
NYSE:ABBV
312.7B USD 15.3
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 17.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 24
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 9.9
US
Epizyme Inc
F:EPE
94.1B EUR -514.1
AU
CSL Ltd
ASX:CSL
133.6B AUD 20.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 16.2
US
Seagen Inc
F:SGT
39.3B EUR -58.7
NL
argenx SE
XBRU:ARGX
34.5B EUR -104.5
EBITDA Growth
KR
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Average EV/EBITDA: 16.4
11.5
60%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
10.6
2-Years Forward
EV/EBITDA
9.2
3-Years Forward
EV/EBITDA
7.3

See Also

Discover More